Michael Nofi
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Michael P.
Nofi is currently Chief Financial Officer at Parlux Fragrances LLC and will be Chief Financial Officer at Edgewise Therapeutics, Inc. starting in 2025.
Formerly, Mr. Nofi was Chief Financial Officer at Perfumania Holdings, Inc. from 2017 to 2018 and Chief Accounting Officer at Springworks Therapeutics, Inc. from 2019 to 2025.
Mr. Nofi completed undergraduate studies at Villanova University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Directeur Financier/CFO | 10/11/2025 |
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Directeur Financier/CFO | - |
| Sociétés | Poste | Fin |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/07/2025 |
| PERFUMANIA HOLDINGS, INC. | Directeur Financier/CFO | 01/10/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Parlux Fragrances LLC
Parlux Fragrances LLC Household/Personal CareConsumer Non-Durables Manufactures a broad line of toiletries, perfumes and colognes | Consumer Non-Durables |
Perfumania Holdings, Inc.
Perfumania Holdings, Inc. Specialty StoresRetail Trade Retails and distributes perfumes & fragrances | Retail Trade |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national